Get the Stockscreener App
7.13
3.33%
0.23
After Hours:
7.13
Passage Bio Inc stock is traded at $7.13, with a volume of 20,803.
It is up +3.33% in the last 24 hours and up +12.46% over the past month.
Passage Bio Inc is a genetic medicines company. The company is focused on developing transformative therapies for rare, monogenic CNS disorders. It has pipeline products such as GM1 Gangliosidosis, Frontotemporal dementia, and Krabbe Disease. The Company operates in a single reportable segment, developing and advancing genetic medicines designed to target critical underlying pathology of neurodegenerative diseases.
See More
Previous Close:
$6.90
Open:
$6.84
24h Volume:
20,803
Relative Volume:
0.08
Market Cap:
$22.66M
Revenue:
-
Net Income/Loss:
$-68.80M
P/E Ratio:
-6.094
EPS:
-1.17
Net Cash Flow:
$-59.06M
1W Performance:
-5.44%
1M Performance:
+12.46%
6M Performance:
+1,298%
1Y Performance:
+857.05%
1-Day Range:
$6.63
$7.13
1-Week Range:
$6.63
$7.70
52-Week Range:
$0.257
$7.75
Passage Bio Inc Stock (PASG) Company Profile
Name
Passage Bio Inc
Sector
Industry
Phone
(267) 866-0312
Address
ONE COMMERCE SQUARE, PHILADELPHIA, PA
Compare PASG with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PASG
Passage Bio Inc
|
7.13 | 21.93M | 0 | -68.80M | -59.06M | -1.17 |
|
VRTX
Vertex Pharmaceuticals Inc
|
391.02 | 100.52B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
580.70 | 61.43B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
446.51 | 59.29B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
712.20 | 43.09B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
306.05 | 35.42B | 3.81B | -644.79M | -669.77M | -6.24 |
Passage Bio Inc Stock (PASG) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-29-24 | Resumed | Wedbush | Outperform |
| Sep-03-24 | Initiated | Rodman & Renshaw | Buy |
| Mar-08-22 | Downgrade | JP Morgan | Overweight → Neutral |
| Jan-19-22 | Downgrade | Goldman | Buy → Neutral |
| Jul-01-21 | Initiated | Raymond James | Outperform |
| Jun-15-21 | Initiated | BTIG Research | Buy |
| Mar-04-21 | Upgrade | Goldman | Neutral → Buy |
| Feb-04-21 | Initiated | Guggenheim | Buy |
| Jan-25-21 | Initiated | Wedbush | Outperform |
| Jan-04-21 | Upgrade | JP Morgan | Neutral → Overweight |
| Dec-11-20 | Initiated | Citigroup | Neutral |
| Aug-14-20 | Downgrade | JP Morgan | Overweight → Neutral |
| Jun-25-20 | Downgrade | Goldman | Buy → Neutral |
| Mar-25-20 | Initiated | Chardan Capital Markets | Buy |
| Mar-24-20 | Initiated | Cowen | Outperform |
| Mar-24-20 | Initiated | Goldman | Buy |
| Mar-24-20 | Initiated | JP Morgan | Overweight |
View All
Passage Bio Inc Stock (PASG) Latest News
Can Passage Bio Inc. recover in the next quarterMarket Risk Summary & Reliable Intraday Trade Alerts - Newser
How hedge fund analytics apply to Passage Bio Inc. stock2025 Dividend Review & Weekly Setup with ROI Potential - Newser
Chart overlay techniques for tracking Passage Bio Inc.Weekly Gains Summary & Daily Chart Pattern Signals - Newser
How to forecast Passage Bio Inc. trends using time seriesJuly 2025 Pullbacks & Growth Focused Stock Reports - Newser
Long term hold vs stop loss in Passage Bio Inc.Weekly Trend Summary & High Accuracy Trade Signal Alerts - Newser
Is it time to cut losses on Passage Bio Inc.2025 Market Outlook & AI Driven Stock Movement Reports - Newser
What indicators show strength in Passage Bio Inc.2025 Market Trends & Low Risk High Win Rate Stock Picks - Newser
Backtesting results for Boundless Bio Inc. trading strategiesJuly 2025 Short Interest & Short-Term High Return Strategies - Newser
When is the best time to exit Passage Bio Inc.Weekly Profit Recap & Stock Market Timing Techniques - Newser
Chart based exit strategy for Passage Bio Inc.2025 Biggest Moves & Weekly Watchlist for Hot Stocks - Newser
Will Passage Bio Inc. stock recover after recent dropWeekly Investment Recap & Weekly Watchlist of Top Performers - Newser
Passage Bio Inc. Volume Confirms Breakout — Analysts Bullish getLinesFromResByArray error: size == 0 - thegnnews.com
Measuring Passage Bio Inc.’s beta against major indicesIndex Update & Weekly Stock Performance Updates - Newser
Will Passage Bio Inc. stock go up soonJuly 2025 Patterns & Fast Gain Stock Trading Tips - Newser
Sentiment analysis tools applied to Passage Bio Inc.July 2025 Rallies & Detailed Earnings Play Strategies - Newser
Technical signs of recovery in Passage Bio Inc.2025 Trading Volume Trends & Real-Time Market Trend Scan - Newser
Is a relief rally coming for Passage Bio Inc. holdersEarnings Risk Report & Step-by-Step Trade Execution Guides - Newser
Visual analytics tools that track Passage Bio Inc. performanceIndex Update & Safe Entry Zone Tips - Newser
Passage Bio Inc. stock outlook for YEARInflation Watch & Real-Time Chart Pattern Alerts - Newser
Will Passage Bio Inc. bounce back from current supportQuarterly Portfolio Summary & Intraday High Probability Alerts - Newser
Understanding Passage Bio Inc.’s price movementTrade Signal Summary & Weekly High Return Stock Forecasts - Newser
Is It Too Early to Call Recovery in Passage Bio Inc. getLinesFromResByArray error: size == 0 - newsyoung.net
How high can Passage Bio Inc. stock goJuly 2025 WrapUp & Community Trade Idea Sharing Platform - Newser
Is Passage Bio Inc. forming bullish engulfing patternsEarnings Recap Report & Daily Profit Focused Stock Screening - sundaytimes.kr
Passage Bio Inc Stock (PASG) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.96%
1.09%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):